EVOLUTION OF BIOLOGIC TREATMENT, SATISFACTION WITH CONTROL OF DISEASE, AND PATIENT-REPORTED OUTCOMES IN EUROPEAN PATIENTS WITH PSORIATIC ARTHRITIS: A REAL-WORLD STUDY

被引:0
作者
Lucas, J. [1 ]
Wood, R. [1 ]
Piercy, J. [1 ]
Cappelleri, J. C. [2 ]
Kola, B. [3 ]
Chhabra, A. [4 ]
Vasilescu, R. [5 ]
Hsu, M. -A. [2 ]
机构
[1] Adelphi Real World, Bollington, Cheshire, England
[2] Pfizer, Groton, CT USA
[3] Pfizer, Tadworth, England
[4] Pfizer, New York, NY USA
[5] Pfizer, Brussels, Belgium
关键词
D O I
10.1136/annrheumdis-2016-eular.1336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0742
引用
收藏
页码:1158 / 1158
页数:1
相关论文
共 1 条
[1]   Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs [J].
Roberto Soriano, Enrique ;
Laura Acosta-Felquer, Maria ;
Luong, Phat ;
Caplan, Liron .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2014, 28 (05) :793-806